6Pringle KC, Spigos DG, Tan WS, et al. Partial splenic embolization in management of thalassemia major. J Pediatr Surg, 1982,17:884-886.
7Hajjar FM, Pearson HA. Pharmacologic treatment of of thalassemia intermedia with hydroxyurea. J Pediatr, 1994,125:490-492.
8Fucharoen S, Siritanaratktd N, Winichagoon P, etal, Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. Blood, 1996,87:887-892.
1Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with disease [J]. Blood, 2001,97(11):6628-3632
2Steinberg M H, Barton F, Castro O,et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment [J].JAMA ,2003,289 (13) : 1645-1651
3Hoppe C, Vichinsky E, Quirolo K,et al. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease[J]. J Pediatr Hematol Oncol,2000,22(4) :330-334
4Arruda VR, Lima CS, Saad St, et al. Successful use of hydroxyurea in beta-thalassemia major[J]. N Engl J Med, 1997,336(13) :964
5Kumar B ,Saraswat A , Kaur I. Rediscovering hydroxyurea: its role in recalcitrant psoriasis[J] . Invt J Dermatol, 2001,40(8) :530-534
6Fruchtman SM, Mack K, Kaplan ME, et al. From efficacy to safty ,apolycythemia vera study group report on hydroxyurea in patients with polycythemia vera[J].Semin Hematol, 1997,34:17-21
7Piccinini G, Foli A, Comolli G, et al. Complementary antiviral efficacy of hydroxyurea and protease inhibitors in human immunodeficiency virus - infected dendritic cells and lymphocytes [J]. J Virol. 2002,76 (5) :2274-2278
8Lori F,Jessen H ,Lieberman D,et al. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir[J]. J Infect. Dis,1999,180:1827-1832
